Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Debu, Tripathy"'
Autor:
Yen-Shen Lu, Seock-Ah Im, Marco Colleoni, Fabio Franke, Aditya Bardia, Fatima Cardoso, Nadia Harbeck, Sara Hurvitz, Louis Chow, Joohyuk Sohn, Keun Seok Lee, Saul Campos-Gomez, Rafael Villanueva Vazquez, Kyung Hae Jung, K. Govind Babu, Paul Wheatley-Price, Michelino De Laurentiis, Young-Hyuck Im, Sherko Kuemmel, Nagi El-Saghir, Ruth O'Regan, Claudia Gasch, Nadia Solovieff, Craig Wang, Yongyu Wang, Arunava Chakravartty, Yan Ji, Debu Tripathy
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research, vol 28, iss 5
Purpose: Ribociclib plus endocrine therapy (ET) demonstrated a statistically significant progression-free survival and overall survival (OS) benefit in the phase III MONALEESA-7 trial of pre-/perimenopausal patients with hormone receptor (HR)-positiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff6fc5fc3fed4998874ffed5668fb72a
https://escholarship.org/uc/item/6hf2w93b
https://escholarship.org/uc/item/6hf2w93b
Autor:
Amy L. Delson, Gillian L. Hirst, Amy Jo Chien, Bernhard Zimmermann, L.J. van 't Veer, Alexey Aleshin, Denise M. Wolf, Svetlana Shchegrova, Raheleh Salari, AM DeMichele, Laura J. Esserman, H. Pawar, Mark Jesus M. Magbanua, Himanshu Sethi, Antony Tin, S Asare, MC Liu, Lamorna Brown Swigart, Debu Tripathy, Maggie C. Louie, C-Hj Lin, Paul Billings, Christina Yau, H.-T. Wu
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology, vol 32, iss 2
Ann Oncol
Ann Oncol
Author(s): Magbanua, MJM; Swigart, LB; Wu, H-T; Hirst, GL; Yau, C; Wolf, DM; Tin, A; Salari, R; Shchegrova, S; Pawar, H; Delson, AL; DeMichele, A; Liu, MC; Chien, AJ; Tripathy, D; Asare, S; Lin, C-HJ; Billings, P; Aleshin, A; Sethi, H; Louie, M; Zimm
Autor:
Sandra M. Swain, Vincent Antao, Haocheng Li, Debu Tripathy, Joyce O'Shaughnessy, Laura Chu, Ginny Mason, Peter A. Kaufman, Denise A. Yardley, Sara A. Hurvitz, Mohammad Jahanzeb, Adam Brufsky, Hope S. Rugo, Melody A. Cobleigh
Publikováno v:
The oncologist, vol 25, iss 2
The Oncologist
The Oncologist
Background Limited data exist describing real‐world treatment of de novo and recurrent HER2‐positive metastatic breast cancer (MBC). Materials and Methods The Systemic Therapies for HER2‐Positive Metastatic Breast Cancer Study (SystHERs) was a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f85b6f5b4b0427599690acf0ecde9c9
https://escholarship.org/uc/item/3141135z
https://escholarship.org/uc/item/3141135z
Autor:
Nuhad K. Ibrahim, Mary Tagliaferri, Andrew D. Seidman, Javier Cortes, Sara M. Tolaney, Chris Twelves, Alison L. Hannah, Véronique Diéras, Carey K. Anders, Hope S. Rugo, Volkmar Müller, Debu Tripathy
Publikováno v:
Future oncology (London, England), vol 15, iss 19
The increasing incidence of breast cancer brain metastases is a major clinical problem with its associated poor prognosis and limited treatment options. The long-acting topoisomerase-1 inhibitor, etirinotecan pegol, was designed to preferentially acc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53e2f797b18ae325acd539299fa0252d
https://escholarship.org/uc/item/8dd948b6
https://escholarship.org/uc/item/8dd948b6
Autor:
Debu Tripathy, Susan Moran, Elizabeth Olek, Linda D. Bosserman, Richard Bryce, Jack A. Di Palma, Hope S. Rugo
Publikováno v:
Breast cancer research and treatment, vol 175, iss 1
Breast Cancer Research and Treatment
Breast Cancer Research and Treatment
Purpose Diarrhea is recognized as a common adverse event associated with tyrosine kinase inhibitors (TKIs), with those targeting the ErbB family of receptors being associated with the highest rate of diarrhea. Methods This paper reviews data on the i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::008266424a12d12d1233d9a4b3427a33
https://escholarship.org/uc/item/3kw0t53x
https://escholarship.org/uc/item/3kw0t53x
Autor:
Naoto T. Ueno, Ana M. Gonzalez-Angulo, Agda Karina Eterovic, Napa Parinyanitikul, Wanding Zhou, Powel H. Brown, Lakshmy Nair, Xiaofeng Zheng, Gordon B. Mills, Ken Chen, Shuying Liu, Xiudong Lei, Debu Tripathy, Gabriel N. Hortobagyi, Mihai Gagea, Mariana Chavez-MacGregor, John Mendelsohn, Funda Meric-Bernstam, Bailiang Wang
Publikováno v:
Oncotarget, vol 6, iss 5
Oncotarget
Oncotarget
// Shuying Liu 1,2 , Funda Meric-Bernstam 3 , Napa Parinyanitikul 1 , Bailiang Wang 1 , Agda K. Eterovic 2 , Xiaofeng Zheng 4 , Mihai Gagea 5 , Mariana Chavez-MacGregor 1 , Naoto T. Ueno 1,6 , Xiudong Lei 7 , Wanding Zhou 4 , Lakshmy Nair 1 , Debu Tr
Autor:
Cheng Quah, Debu Tripathy, Denise A. Yardley, Marianne Ulcickas Yood, Bongin Yoo, Hope S. Rugo, Adam Brufsky, Peter A. Kaufman, Musa Mayer
Publikováno v:
Breast cancer research and treatment, vol 145, iss 3
Breast Cancer Research and Treatment
Breast Cancer Research and Treatment
Improvements in screening and adjuvant therapy for breast cancer are associated with decreased recurrence, which may have the effect of increasing the proportion of patients presenting with first-line de novo versus recurrent metastatic breast cancer
Autor:
Debu Tripathy, Javier Cortes, Sara A. Hurvitz, Sunil Verma, Kaveh Riahi, Kathy D. Miller, Joseph G. Reynolds, István Molnár, Thomas Wickham, Ian E. Krop, Denise A. Yardley
Publikováno v:
BMC cancer, vol 16, iss 1
BMC Cancer
BMC Cancer
Background Human epidermal growth factor receptor 2 (HER2)-positive breast cancer is a particularly aggressive form of the disease, and ultimately progresses in patients with metastases on standard therapies. Anthracyclines, such as doxorubicin, are
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36066e07acaf59b1fd040bb8d35892aa
https://escholarship.org/uc/item/7b19m18n
https://escholarship.org/uc/item/7b19m18n
Autor:
Giske Ursin, Debra Hawes, Heather R. Macdonald, Min-Ying Su, Malcolm C. Pike, Christy A. Russell, Agustin A. Garcia, Anna H. Wu, Darcy V. Spicer, Sue Ellen Martin, Chiu-Chen Tseng, Debu Tripathy, Pulin Sheth, Linda Hovanessian-Larsen
Publikováno v:
Cancer prevention research (Philadelphia, Pa.), vol 8, iss 10
Wu, AH; Spicer, D; Garcia, A; Tseng, CC; Hovanessian-Larsen, L; Sheth, P; et al.(2015). Double-blind randomized 12-month soy intervention had no effects on breast MRI fibroglandular tissue density or mammographic density. Cancer Prevention Research, 8(10), 942-951. doi: 10.1158/1940-6207.CAPR-15-0125. UC Irvine: Retrieved from: http://www.escholarship.org/uc/item/9wk4k8d5
Wu, AH; Spicer, D; Garcia, A; Tseng, CC; Hovanessian-Larsen, L; Sheth, P; et al.(2015). Double-blind randomized 12-month soy intervention had no effects on breast MRI fibroglandular tissue density or mammographic density. Cancer Prevention Research, 8(10), 942-951. doi: 10.1158/1940-6207.CAPR-15-0125. UC Irvine: Retrieved from: http://www.escholarship.org/uc/item/9wk4k8d5
Soy supplementation by patients with breast cancer remains controversial. No controlled intervention studies have investigated the effects of soy supplementation on mammographic density in patients with breast cancer. We conducted a double-blind, ran
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb80b830e3d7c71a70903d1aca3045eb
https://escholarship.org/uc/item/9wk4k8d5
https://escholarship.org/uc/item/9wk4k8d5
Autor:
Bongin Yoo, Musa Mayer, Jessica F. Magidson, M. Ulcickas Yood, Debu Tripathy, Cheng Quah, Peter A. Kaufman, Adam Brufsky, Hope S. Rugo, Denise A. Yardley
Publikováno v:
British journal of cancer, vol 110, iss 11
British Journal of Cancer
British Journal of Cancer
Background: Data characterising long-term survivors (LTS) with human epidermal growth factor receptor 2 (HER2)–positive metastatic breast cancer (MBC) are limited. This analysis describes LTS using registHER observational study data. Methods: A lat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8007202333dc6ee996f826c845e57eb8
https://escholarship.org/uc/item/3q69g6zm
https://escholarship.org/uc/item/3q69g6zm